These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

180 related articles for article (PubMed ID: 34458156)

  • 1. Does Day-to-Day Variability in Stool Consistency Link to the Fecal Microbiota Composition?
    Vork L; Penders J; Jalanka J; Bojic S; van Kuijk SMJ; Salonen A; de Vos WM; Rajilic-Stojanovic M; Weerts ZZRM; Masclee AAM; Pozuelo M; Manichanh C; Jonkers DMAE
    Front Cell Infect Microbiol; 2021; 11():639667. PubMed ID: 34458156
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Identification of an Intestinal Microbiota Signature Associated With Severity of Irritable Bowel Syndrome.
    Tap J; Derrien M; Törnblom H; Brazeilles R; Cools-Portier S; Doré J; Störsrud S; Le Nevé B; Öhman L; Simrén M
    Gastroenterology; 2017 Jan; 152(1):111-123.e8. PubMed ID: 27725146
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Distal colonic transit is linked to gut microbiota diversity and microbial fermentation in humans with slow colonic transit.
    Müller M; Hermes GDA; Canfora EE; Smidt H; Masclee AAM; Zoetendal EG; Blaak EE
    Am J Physiol Gastrointest Liver Physiol; 2020 Feb; 318(2):G361-G369. PubMed ID: 31869241
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Stool and urine trefoil factor 3 levels: associations with symptoms, intestinal permeability, and microbial diversity in irritable bowel syndrome.
    Heitkemper MM; Cain KC; Shulman RJ; Burr RL; Ko C; Hollister EB; Callen N; Zia J; Han CJ; Jarrett ME
    Benef Microbes; 2018 Apr; 9(3):345-355. PubMed ID: 29633639
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Differences in gut microbiota associated with age, sex, and stool consistency in healthy Japanese subjects.
    Takagi T; Naito Y; Inoue R; Kashiwagi S; Uchiyama K; Mizushima K; Tsuchiya S; Dohi O; Yoshida N; Kamada K; Ishikawa T; Handa O; Konishi H; Okuda K; Tsujimoto Y; Ohnogi H; Itoh Y
    J Gastroenterol; 2019 Jan; 54(1):53-63. PubMed ID: 29926167
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Oral and Stool Microbiome Coalescence and Its Association With Antibiotic Exposure in Acute Leukemia Patients.
    Franklin S; Aitken SL; Shi Y; Sahasrabhojane PV; Robinson S; Peterson CB; Daver N; Ajami NA; Kontoyiannis DP; Shelburne SA; Galloway-Peña J
    Front Cell Infect Microbiol; 2022; 12():848580. PubMed ID: 35433514
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Fecal microbiota transplantation in the treatment of irritable bowel syndrome: a single-center prospective study in Japan.
    Hamazaki M; Sawada T; Yamamura T; Maeda K; Mizutani Y; Ishikawa E; Furune S; Yamamoto K; Ishikawa T; Kakushima N; Furukawa K; Ohno E; Honda T; Kawashima H; Ishigami M; Nakamura M; Fujishiro M
    BMC Gastroenterol; 2022 Jul; 22(1):342. PubMed ID: 35836115
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Fecal and Mucosa-Associated Intestinal Microbiota in Patients with Diarrhea-Predominant Irritable Bowel Syndrome.
    Maharshak N; Ringel Y; Katibian D; Lundqvist A; Sartor RB; Carroll IM; Ringel-Kulka T
    Dig Dis Sci; 2018 Jul; 63(7):1890-1899. PubMed ID: 29777439
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Mucosa-Associated Microbiota in Patients with Irritable Bowel Syndrome: A Comparison of Subtypes.
    Matsumoto H; Shiotani A; Katsumata R; Fukushima S; Handa Y; Osawa M; Murao T; Handa O; Umegaki E; Inoue R; Naito Y
    Digestion; 2021; 102(1):49-56. PubMed ID: 33271532
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Relationships of Microbiome Markers With Extraintestinal, Psychological Distress and Gastrointestinal Symptoms, and Quality of Life in Women With Irritable Bowel Syndrome.
    Hollister EB; Cain KC; Shulman RJ; Jarrett ME; Burr RL; Ko C; Zia J; Han CJ; Heitkemper MM
    J Clin Gastroenterol; 2020 Feb; 54(2):175-183. PubMed ID: 30148765
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Clinical response to fecal microbiota transplantation in patients with diarrhea-predominant irritable bowel syndrome is associated with normalization of fecal microbiota composition and short-chain fatty acid levels.
    Mazzawi T; Hausken T; Hov JR; Valeur J; Sangnes DA; El-Salhy M; Gilja OH; Hatlebakk JG; Lied GA
    Scand J Gastroenterol; 2019 Jun; 54(6):690-699. PubMed ID: 31190584
    [No Abstract]   [Full Text] [Related]  

  • 12. Stool consistency is strongly associated with gut microbiota richness and composition, enterotypes and bacterial growth rates.
    Vandeputte D; Falony G; Vieira-Silva S; Tito RY; Joossens M; Raes J
    Gut; 2016 Jan; 65(1):57-62. PubMed ID: 26069274
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Baseline gut microbial profiles are associated with the efficacy of
    Hong G; Li Y; Yang M; Li G; Jin Y; Xiong H; Qian W; Hou X
    Scand J Gastroenterol; 2023 Apr; 58(4):339-348. PubMed ID: 36281578
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Comparison of rectal swab, glove tip, and participant-collected stool techniques for gut microbiome sampling.
    Short MI; Hudson R; Besasie BD; Reveles KR; Shah DP; Nicholson S; Johnson-Pais TL; Weldon K; Lai Z; Leach RJ; Fongang B; Liss MA
    BMC Microbiol; 2021 Jan; 21(1):26. PubMed ID: 33446094
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Analysis of the dynamic changes in gut microbiota in patients with extremely severe burns by 16S ribosomal RNA high-throughput sequencing technology].
    Pan YY; Fan YF; Li JL; Cui SY; Huang N; Jin GY; Chen C; Zhang C
    Zhonghua Shao Shang Za Zhi; 2020 Dec; 36(12):1159-1166. PubMed ID: 33379852
    [No Abstract]   [Full Text] [Related]  

  • 16. Distinctions Between Fecal and Intestinal Mucosal Microbiota in Subgroups of Irritable Bowel Syndrome.
    Hou Y; Dong L; Lu X; Shi H; Xu B; Zhong W; Ma L; Wang S; Yang C; He X; Zhao Y; Wang S
    Dig Dis Sci; 2022 Dec; 67(12):5580-5592. PubMed ID: 35879512
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Temporal stability of fecal metabolomic profiles in irritable bowel syndrome.
    Iribarren C; Savolainen O; Sapnara M; Törnblom H; Simrén M; Magnusson MK; Öhman L
    Neurogastroenterol Motil; 2024 Mar; 36(3):e14741. PubMed ID: 38243381
    [TBL] [Abstract][Full Text] [Related]  

  • 18. An Open-Labeled Study on Fecal Microbiota Transfer in Irritable Bowel Syndrome Patients Reveals Improvement in Abdominal Pain Associated with the Relative Abundance of Akkermansia Muciniphila.
    Cruz-Aguliar RM; Wantia N; Clavel T; Vehreschild MJGT; Buch T; Bajbouj M; Haller D; Busch D; Schmid RM; Stein-Thoeringer CK
    Digestion; 2019; 100(2):127-138. PubMed ID: 30423561
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Reproducibility of assessing fecal microbiota in chronic constipation.
    Parthasarathy G; Chen J; Chia N; O'Connor HM; Gaskins HR; Bharucha AE
    Neurogastroenterol Motil; 2017 Oct; 29(10):1-10. PubMed ID: 28752633
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Differences in gut microbial composition correlate with regional brain volumes in irritable bowel syndrome.
    Labus JS; Hollister EB; Jacobs J; Kirbach K; Oezguen N; Gupta A; Acosta J; Luna RA; Aagaard K; Versalovic J; Savidge T; Hsiao E; Tillisch K; Mayer EA
    Microbiome; 2017 May; 5(1):49. PubMed ID: 28457228
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.